|
|
|
Insider
Information: |
Jaen Juan C. |
Relationship: |
President |
City: |
Mountain View |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
371,475 |
|
Indirect Shares
|
1,188,233 |
|
|
Direct
Value |
$7,364,775 |
|
|
Indirect Value
|
$20,199,961 |
|
|
Total
Shares |
1,559,708 |
|
|
Total
Value |
$27,564,736 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
7
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
5
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
-71.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Chemocentryx, Inc. |
CCXI |
SVP, Drug Discovery & ... |
2013-03-08 |
30,000 |
|
0 |
Premium* |
|
Arcus Biosciences Inc |
RCUS |
President |
2024-02-27 |
341,475 |
2024-02-27 |
1,188,233 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
92 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 4 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-07 |
4 |
OE |
$4.30 |
$6,687 |
D/D |
1,555 |
54,555 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-15 |
4 |
OE |
$4.30 |
$8,364 |
D/D |
1,945 |
53,700 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-19 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
53,700 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-20 |
4 |
OE |
$4.30 |
$24,084 |
D/D |
5,601 |
50,601 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-21 |
4 |
OE |
$4.30 |
$4,730 |
D/D |
1,100 |
46,100 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-22 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
52,401 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-25 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
52,401 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-26 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
47,401 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-27 |
4 |
OE |
$4.30 |
$32,250 |
D/D |
7,500 |
49,901 |
0 |
- |
|
CCXI |
Chemocentryx, Inc. |
SVP, Drug Discovery & CSO |
|
2013-02-28 |
4 |
OE |
$4.30 |
$21,926 |
D/D |
5,099 |
50,000 |
0 |
- |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2021-06-16 |
4 |
S |
$24.13 |
$52,707 |
D/D |
(2,182) |
200,961 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2021-06-17 |
4 |
S |
$23.68 |
$63,344 |
D/D |
(2,675) |
198,286 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2021-12-16 |
4 |
S |
$39.59 |
$34,448 |
D/D |
(865) |
202,265 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2021-12-17 |
4 |
S |
$38.79 |
$44,715 |
D/D |
(1,108) |
201,157 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2022-06-16 |
4 |
S |
$20.72 |
$48,340 |
D/D |
(2,333) |
212,574 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2022-06-17 |
4 |
S |
$21.71 |
$56,116 |
D/D |
(2,537) |
210,037 |
0 |
% |
|
RCUS |
Arcus Biosciences Inc |
President |
|
2022-12-16 |
4 |
S |
$30.66 |
$136,407 |
D/D |
(4,436) |
218,258 |
0 |
% |
|
92 Records found
|
|
Page 4 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|